85475-10-1

Basic information

• Product Name: benzyl 4-(2-chloroacetyl)piperidine-1-carboxylate
• Synonyms: benzyl 4-(2-chloroacetyl)piperidine-1-carboxylate
• CAS NO: 85475-10-1
• Molecular Weight: 295.766
• Mol File: 85475-10-1.mol

Chemical Properties

• CAS DataBase Reference: benzyl 4-(2-chloroacetyl)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 4-(2-chloroacetyl)piperidine-1-carboxylate(85475-10-1)
• EPA Substance Registry System: benzyl 4-(2-chloroacetyl)piperidine-1-carboxylate(85475-10-1)

Safety Data

• Hazardous Substances Data: 85475-10-1(Hazardous Substances Data)

Upstream product

• 79-37-8 oxalyl dichloride 
• 10314-98-4 1-benzyloxycarbonylpiperidine-4-carboxylic acid 
• 1242142-34-2 C₁₇H₂₃NO₄S 
• 10314-99-5 benzyl 4-(chlorocarbonyl)piperidine-1-carboxylate 
• 18107-18-1 diazomethyl-trimethyl-silane 

Downstream Products

• 271247-33-7 4-(3-trifluoromethylphenyl)-4-oxo-3-(2-methylthiopyrimidin-4-yl)-1-oxo-1-(N-carbobenzoxypiperidin-4-yl)butane 
• 188345-24-6 4-(3-trifluoromethylphenyl)-4-oxo-3-(2-fluoropyridin-4-yl)-1-oxo-1-(N-carbobenzoxypiperidin-4-yl)butane 
• 188343-76-2 benzyl 4-(5-(4-fluorophenyl)-4-(pyridin-4-yl)-1H-pyrrol-2-yl)piperidine-1-carboxylate 
• 188343-77-3 4-(2-(4-fluorophenyl)-5-(1-methylpiperidin-4-yl)-1H-pyrrol-3-yl)pyridine 
• 1426406-57-6 N-(2-(4-(5-(4-fluorophenyl)-4-(pyridin-4-yl)-1H-pyrrol-2-yl)piperidin-1-yl)ethyl)-6-(6-(5-((3aS,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)hexanamido)hexanamide 
• 1426406-59-8 N-(2-(2-(2-(2-(3-(2-(4-(5-(4-fluorophenyl)-4-(pyridin-4-yl)-1H-pyrrol-2-yl)piperidin-1-yl)ethylamino)-3-oxopropoxy)ethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide 
• 188345-15-5 4-(1-benzyloxycarbonylpiperidin-4-yl)-2-(pyridin-4-yl)-1-(4-fluoro-phenyl)butane-1,4-dione 
• 188345-17-7 4-(1-benzyloxycarbonylpiperidin-4-yl)-2-(pyridin-4-yl)-1 (3-trifluoromethylphenyl)butane-1,4-dione 
• 271247-39-3 C₃₀H₂₈F₃NO₄ 
• 271247-51-9 1-(pyridin-4-yl)-1-oxo-2-(3-trifluoromethylphenyl)-4-oxo-4-(N-carbobenzoxypiperidin-4-yl)butane 
• 271247-36-0 (S)-3-(3-trifluoromethylphenyl)-4-[(2-α-methylbenzylamino)pyrimidin-4-yl]-6-(N-carbobenzoxypiperidin-4-yl)pyridazine 
• 271247-35-9 3-(3-trifluoromethylphenyl)-4-(2-methylsulfonylpyrimidin-4-yl)-6-(N-carbobenzoxypiperidin-4-yl)pyridazine 
• 271247-34-8 3-(3-trifuoromethylphenyl)-4-(2-methylthiopyrimidin-4-yl)-6-(N-carbobenzoxypiperidin-4-yl)pyridazine 
• 271247-18-8 ((S)-1-Phenyl-ethyl)-{4-[6-piperidin-4-yl-3-(3-trifluoromethyl-phenyl)-pyridazin-4-yl]-pyrimidin-2-yl}-amine 

Relevant articles and documents

Chemical probes of a trisubstituted pyrrole to identify its protein target(s) in Plasmodium sporozoites

Malaria is a disease that has a major impact in many developing nations, especially on the African continent. There is a need to develop new therapeutics and prophylactic treatments against it. A trisubstituted pyrrole was recently found to inhibit infect

STEREOSELECTIVE HYDROGENATION OF A KETONE

The present invention relates to a method comprising reducing a ketone of formula (I) with an enantioselective hydrogenating agent to form substantially enantiomerically pure alcohol of formula (II), where R-R4 and m are as defined herein. The method of the present invention is useful for making CCR2 modulators as well as precursors CCR2 modulators.

Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent Melanin-Concentrating Hormone Receptor 1 (MCH-R1) antagonists

A series of 1,3-disubstituted-1H-pyrrole-based antagonists of the human Melanin-Concentrating Hormone Receptor 1 (h-MCH-R1) are reported. High-throughput screening of the AstraZeneca compound collection yielded 1, a hit with moderate affinity towards MCH-

Compounds having cytokine inhibitory activity

There are disclosed compounds of formula (I) and pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis.